TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.
Kathrin HeimBenedikt Bindernull SagarDominik WielandNina HenselSian Llewellyn-LaceyEmma GostickDavid A PriceFlorian EmmerichHildegard VingerhoetAnke R M KraftMarkus CornbergTobias BoettlerChristoph Neumann-HaefelinDietmar ZehnBertram BengschMaike HofmannRobert ThimmePublished in: Gut (2020)
Our data highlight TOX as biomarker specific for dysfunctional virus-specific CD8+ T cells in the context of an actively persisting infection.